»Go to related Japanese page in JPubb
»Go to "Osaka" Company Directory


Loading

Press Releases from "Osaka" Non-listed Companies

« Previous12345678910Next »
1 - 50 of 500 for your search
News Release Full-scale commencement of distributed power supply model business through biomass gasification power generation utilizing rice husks in Myanmar
[ Yanmar Holdings Co., Ltd. | Machinery | 2017-03-23]
NIPPON LIFE SIGNS THE UNITED NATIONS PRINCIPLES FOR RESPONSIBLE INVESTMENT-Regarding Further Enhancement of ESG Investment and Financing-[276KB]
[ Nippon Life Insurance Company | Insurance | 2017-03-21]
Mitsubishi Tanabe Pharma Corporation Strategically Strengthens Its Foundation in the Field of Inflammatory Bowel Disease Mitsubishi Tanabe Pharma signs co-promotion agreement with Janssen Pharmaceutical K.K. for STELARA for an indication of Crohn’s disease
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2017-02-03]
Biogen and Mitsubishi Tanabe Pharma Terminate the License Agreement on MT-1303
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2017-01-27]
不燃化粧板「セラリエZ」発売。
[ C.I. Takiron Corp. | Chemicals | 2016-11-08]
Basic Agreement on the Establishment of a Joint Venture
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-11-07]
Announcement of FY2016 2nd Quarter Financial Results
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-11-01]
Mitsubishi Tanabe Pharma Takes on the Challenge of Cell Therapy with the Conclusion of an Invossa Licensing Agreement with Kolon Life Science Aiming for therapy that addresses unmet medical needs in the treatment of knee osteoarthritis
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-11-01]
Revision to Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2017
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-10-25]
Joint research identifies hit compounds for the development of a new treatment for malaria Mitsubishi Tanabe Pharma uses its compound library in joint research activities with Medicines for Malaria Venture ―Targeting treatments for infectious diseases that burden the developing world―
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-10-05]
Execution of Basic Agreement for Sales Anti-Allergy Agent, Rupatadine Tablets
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-10-04]
2016年9月15日(木)～16日（金）にナレッジキャピタルコングレコンベンションホール（大阪）にて開催されます第25回日本形成外科学会基礎学術集会にてブース展示を行います。
[ C.I. Takiron Corp. | Chemicals | 2016-09-12]
Application for partial change in administration/dosage for Crohn's disease for REMICADE for I.V. Infusion 100, an anti-human TNFα monoclonal antibody
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-09-06]
FDA Accepts Mitsubishi Tanabe Pharma’s NDA Filing for Edaravone to Treat ALS
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-08-30]
Valixa Tablet 450mg Approval for Additional Indication in Japan for the Prevention of CMV disease in organ transplant patients
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-08-26]
Application filed in Japan fortype 2 diabetes mellitus treatment agent combination drug - Combination of selective DPP-4 inhibitor TENELIA Tablets and SGLT2 inhibitor CANAGLU Tablets -
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-08-23]
Announcement of FY2016 1st Quarter Financial Results
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-08-02]
この度2016年7月13日(水) ～7月15日(金)の日程にて、東京ビッグサイトで開催されます≪第10回 オフィス防災EXPO≫に以下の弊社製品を出展いたします。 ≪第7回省エネ節電・節電EXPO≫採光建材事業部との共同出展となります。 ＜防災事業推進部＞ ・高輝度長残光蓄光製品 "ルミセーフシリーズ" ・環境発電製品 "LED発電床" ・軽量止水板 "フラッドセーフシリーズ" 等を出展いたします。 ＜採光建材事業部＞ 今回のテーマは【光の拡散】です。光の拡散を体験出来るコーナーを設けて、工場・物流施設へトップライト、ハイサイドライト、文教施設へ庇、ハイサイドライトの提案を展示し、硝子窓、硝子製トップライトとの差別化を図ります。 また、下地レストップライトと30分耐火仕様のルメスカイライト展示し、施主・設計事務所・ゼネコンに向けて提案営業を行います。 御時間御座いましたら、是非とも弊社ブースにお立ち寄り下さいます様、お願い致します。ブース番号は「西4ホール 24-1」となっております。
[ C.I. Takiron Corp. | Chemicals | 2016-07-05]
Regarding Nomination Committee and Compensation Committee
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-06-22]
Mitsubishi Tanabe Pharma Submits New Drug Application for Edaravone to Treat ALS in the United States
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-06-20]
Mitsubishi Tanabe Pharma contribute funding to Global Health Innovative Technology Fund
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-06-06]
2016年5月26日(木)～27日（金）にナレッジキャピタル コングレコンベンションセンターにて開催されます第40回日本口蓋裂学会総会にてブース展示を行います。また、27日(金)にランチョンセミナーを開催いたします。
[ C.I. Takiron Corp. | Chemicals | 2016-05-18]
Approval of REMICADE for I.V. Infusion 100, an Anti-Human TNFα Monoclonal Antibody, for a Partial Change in Dosage and Usage in Psoriasis
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-05-13]
Notice of Dividend of Retained Earnings
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-05-11]
Change of Representative Director, Director and Corporate Auditor
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-04-27]
MT Pharma Singapore Pte. Ltd. Starts Business Operations Mitsubishi Tanabe Pharma's Subsidiary in Singapore
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-04-04]
Astellas and Mitsubishi Tanabe Pharma Execute Agreement for Share of Compound Libraries
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-03-29]
Valixa Tablet 450 mg Application for Additional Indication in Japan for the Prevention of CMV disease in organ transplant patients Public Knowledge-based Application
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-03-22]
Notice regarding change of current commercialization scheme to new strategic co-promotion partnership in Japan for RA treatment agent Simponi subcutaneous injection 50 mg syringe (generic name: golimumab)
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-03-10]
2017年卒採用を開始しました。リクナビからエントリーしてください。
[ C.I. Takiron Corp. | Chemicals | 2016-03-01]
Mitsubishi Tanabe Pharma Enhances Operations in the United States
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-02-23]
Announcement of FY2015 3rd Quarter Financial Results
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-02-03]
Notice Regarding Results of Early Retirement Program
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2016-02-03]
Remicade for I.V. Infusion 100 Approval of Additional Indication for Kawasaki Disease World First Biologic Treatment
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-12-21]
RADICUT inj. 30mg and RADICUT BAG for I.V. Infusion 30mg An import and Marketing Permission for ALS in South Korea
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-12-21]
RADICUT inj. 30mg and RADICUT Infusion inj. 30mg An import and Marketing Permission for ALS in South Korea
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-12-21]
Akebia and Mitsubishi Tanabe Pharma Announce Collaboration to Develop and Commercialize Vadadustat in Asia
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-12-15]
Formulation of the Medium-Term Management Plan 16-20: Open Up the Future
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-11-30]
Announcement of an approval for an additional indication for the Anti-depressant, Lexapro Tablets 10 mg in Japan
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-11-20]
Announcement of FY2015 2nd Quarter Financial Results
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-10-30]
Notice Regarding Implementation of Early Retirement Program
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-10-30]
Medicago Engaged by the Canadian Government Produce Ebola Monoclonal Antibodies
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-10-30]
Agreement to partner with National Australia Bank and acquire MLC's life insurance business
[ Nippon Life Insurance Company | Insurance | 2015-10-28]
Mitsubishi Tanabe Pharma and Regeneron Conclude Collaboration Agreement for Fasinumab, NGF Antibody
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-10-02]
Revision to Consolidated Financial Forecasts for Fiscal Year Ending March 31, 2016
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-09-30]
MedImmune and Tanabe Research Laboratories / Mitsubishi Tanabe Pharma Enter into Strategic Collaboration and Licensing Agreement for the Development of Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugates to Treat Cancer
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-09-23]
Notice Regarding Worldwide Patent and Know-how Transfer, Excluding Japan and Certain Other Territories in Asia, for TA-8995 (CETP inhibitor), a Treatment Agent for Dyslipidemia
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-09-17]
MT-4666 in Alzheimer’s Disease Discontinuation of Global Phase 3 Clinical Trial Program in Japan
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-09-15]
Biogen and Mitsubishi Tanabe Pharma Conclude a License Agreement on MT-1303, a Therapeutic Agent for Autoimmune Diseases
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-09-09]
Approval of REMICADE for I.V. Infusion 100, an Anti-Human TNFα Monoclonal Antibody, for Additional Indications for Entero-Behcet's Disease, Neuro-Behcet's Disease, and Vasculo-Behcet's Disease
[ Mitsubishi Tanabe Pharma Corporation | Pharmaceuticals | 2015-08-24]
« Previous12345678910Next »


What's New
Top Searches

Keyword

Company
1. Maruha Nichiro Corp.
2. Kubota Corporation
3. Ikegami Tsushinki Co., Ltd.
4. Freakout Holdings, Inc.
5. Ministry of Justice

Industry
1. Construction
2. Media & Telecoms
3. Real Estate
4. Transportation Equipment
5. Nonferrous Metals

Prefecture
1. Osaka
2. Okinawa
3. Ishikawa
4. Okayama
5. Saitama

Stock Exchange
1. SSE (Sapporo) ALL
2. NSE2(MAIN)
3. FSE (Fukuoka) ALL
4. NSE1(PREMIER)
5. Ambitious

Press Conferense Videos
Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays Sharp and Semiconductor Energy Laboratory Jointly Develop New Oxide Semiconductor Technology That Will Revolutionize Displays
Sharp Corporation 2012/06/01
More Videos
Latest Press Release Search

Save favorite searches Hot keywords

Fukushima | power supply | cloud | solar
*NOTE: Recommended keywords shown above.
Your Most Recently Viewed Companies
Visit any of the company pages in JPubb, and your most recently viewed companies will automatically show up here.

Erase all This feature:ON How to use
Most Popular: Osaka
1. Panasonic to Launch "Space Player(TM)" to Create New Possibilities for Ambient Lighting
Panasonic Holdings Corp. 2014/02/27
2. Kobayashi Pharmaceutical Reports Financial Results for the Year Ended March 31, 2005
Kobayashi Pharmaceutical Co., Ltd. 2009/07/07
3. Notice on an distribution of retained earnings
Kubota Corporation 2009/05/13
4. Notice on an distribution of retained earnings
Kubota Corporation 2008/05/13
5. [Exhibition] CEATEC JAPAN 2007 Panasonic Booth Info now available
Panasonic Holdings Corp. 2007/09/19
Feed
Releases by Prefecture
Hokkaido | Aomori | Iwate | Miyagi | Akita | Yamagata | Fukushima

Ibaraki | Tochigi | Gunma | Saitama | Chiba | Tokyo | Kanagawa

Niigata | Toyama | Ishikawa | Fukui | Yamanashi | Nagano

Gifu | Shizuoka | Aichi | Mie

Shiga | Kyoto | Osaka | Hyogo | Nara | Wakayama

Tottori | Shimane | Okayama | Hiroshima | Yamaguchi

Tokushima | Kagawa | Ehime | Kochi

Fukuoka | Saga | Nagasaki | Kumamoto | Oita | Miyazaki | Kagoshima | Okinawa
Releases by Stock Exchange
TSE (Tokyo) All | TSE1(PRIME) | TSE2(STANDARD) | TSE Growth | TOKYO PRO Market

NSE (Nagoya) All | NSE1(PREMIER) | NSE2(MAIN) | NSE NEXT | NSE-only

SSE (Sapporo) All | Ambitious | SSE-only

FSE (Fukuoka) All | Q-Board | FSE-only
Press Release Search
Company
Industry
Prefecture
Stock Exchange
Date
(yyyy/mm/dd)		 //～
//
Listed or Non-listed
*NOTE: Please input only items to be specified.
*NOTE: The "date" here means the one on which a press release is uploaded on this website. So it isn't necessarily the same as its official announcement date.
Company Search
Company
Industry
Prefecture
Stock Exchange
Listed or Non-listed
*NOTE: Please input only items to be specified.